Evogene Ltd. (EVGN) vs Kairos Pharma, Ltd. (KAPA)
Evogene Ltd. and Kairos Pharma, Ltd. are both Biotechnology companies. Evogene Ltd. and Kairos Pharma, Ltd. are of similar size ($6.3M and $6.1M). Kairos Pharma, Ltd. has the higher net margin (0.00% vs −547.6%) and the lower return on invested capital (−322.9% vs 0.00%). Across the 12 metrics below, Evogene Ltd. leads on 6 and Kairos Pharma, Ltd. on 6.
Valuation
Profitability
| Metric | EVGN | KAPA | Biotechnology median |
|---|---|---|---|
| Gross margin | (67.59%) | — | 65.16% |
| Operating margin | (851.42%) | 0.00% | 0.00% |
| Net margin | (547.62%) | 0.00% | 0.00% |
| Free cash flow margin | (650.63%) | 0.00% | 0.00% |
| Return on equity | (100.03%) | (113.96%) | (57.72%) |
| Return on assets | (38.31%) | (104.32%) | (49.22%) |
| Return on invested capital | 0.00% | (322.91%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack